Filing Details

Accession Number:
0000950170-25-075515
Form Type:
13G Filing
Publication Date:
2025-05-19 20:00:00
Filed By:
Longitude Capital Partners V, LLC
Company:
Cytomx Therapeutics Inc. (NASDAQ:CTMX)
Filing Date:
2025-05-20
SEC Url:
13G Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Beneficially Owned Number of Shares Beneficially Owned Number of Aggregate Shares Percent of Class
Longitude Capital Partners V, LLC 0 11,538,461 7.3%
Longitude Venture Partners V, L.P. 0 11,538,461 7.3%
Patrick G. Enright 0 11,538,461 7.3%
Juliet Tammenoms Bakker 0 11,538,461 7.3%
Filing





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G



Comment for Type of Reporting Person:  All such shares are held of record by LVPV (as defined in Item 2(a) below). LCPV (as defined in Item 2(a) below) is the general partner of LVPV and may be deemed to have voting, investment and dispositive power with respect to these securities. Patrick G. Enright and Juliet Tammenoms Bakker are the managing members of LCPV and may each be deemed to share voting, investment and dispositive power with respect to these securities. Based on 157,544,369 shares of Common Stock (as defined in Item 2(d) below) outstanding as reported by the Issuer (as defined in Item 1(a) below) in its prospectus supplement dated May 12, 2025 and filed with the Securities and Exchange Commission (the Commission) on May 12, 2025 (the Prospectus Supplement).


SCHEDULE 13G



Comment for Type of Reporting Person:  All such shares are held of record by LVPV. LCPV is the general partner of LVPV and may be deemed to have voting, investment and dispositive power with respect to these securities. Patrick G. Enright and Juliet Tammenoms Bakker are the managing members of LCPV and may each be deemed to share voting, investment and dispositive power with respect to these securities. Based on 157,544,369 shares of Common Stock outstanding as reported by the Issuer in its Prospectus Supplement.


SCHEDULE 13G



Comment for Type of Reporting Person:  All such shares are held of record by LVPV. LCPV is the general partner of LVPV and may be deemed to have voting, investment and dispositive power with respect to the securities held by LVPV. Mr. Enright is a managing member of LCPV and may be deemed to share voting, investment and dispositive power with respect to these securities. Based on 157,544,369 shares of Common Stock outstanding as reported by the Issuer in its Prospectus Supplement.


SCHEDULE 13G



Comment for Type of Reporting Person:  All such shares are held of record by LVPV. LCPV is the general partner of LVPV and may be deemed to have voting, investment and dispositive power with respect to the securities held by LVPV. Ms. Bakker is a managing member of LCPV and may be deemed to share voting, investment and dispositive power with respect to these securities. Based on 157,544,369 shares of Common Stock outstanding as reported by the Issuer in its Prospectus Supplement.


SCHEDULE 13G


 
Longitude Capital Partners V, LLC
 
Signature:/s/ Cristiana Blauth Oliveira
Name/Title:Cristiana Blauth Oliveira, Authorized Signatory
Date:05/20/2025
 
Longitude Venture Partners V, L.P.
 
Signature:/s/ Cristiana Blauth Oliveira
Name/Title:Cristiana Blauth Oliveira, Authorized Signatory
Date:05/20/2025
 
Patrick G. Enright
 
Signature:/s/ Cristiana Blauth Oliveira
Name/Title:Cristiana Blauth Oliveira, as attorney-in-fact for Patrick G. Enright
Date:05/20/2025
 
Juliet Tammenoms Bakker
 
Signature:/s/ Cristiana Blauth Oliveira
Name/Title:Cristiana Blauth Oliveira, as attorney-in-fact for Juliet Tammenoms Bakker
Date:05/20/2025